Skip to contentPolaris Venture Partners Founders' Fund V, L.P. — Cardlytics, Inc. insider: 120 transactions · InsiderLensPolaris Venture Partners Founders' Fund V, L.P.
- 10% owner at INTERNET BRANDS, INC. · on record since Jul 10, 2008
- 10% owner at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- 10% owner at BIND Therapeutics, Inc · on record since Sep 27, 2013
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Feb 11, 2014
- 10% owner at Cerulean Pharma Inc. · on record since Apr 15, 2014
- 10% owner at OCULAR THERAPEUTIX, INC · on record since Jul 31, 2014
- 10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
- 10% owner at Ruthigen, Inc. · on record since Jun 25, 2015
- 10% owner at Lifeline Systems, Inc. · on record since May 14, 2015
- 10% owner at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jul 19, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at Cardlytics, Inc. · on record since Feb 15, 2018
- Director at Cardlytics, Inc. · on record since Aug 9, 2018
- 10% owner at Phreesia, Inc. · on record since Jul 24, 2019
- 10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- See Remarks at ALLIED DEFENSE GROUP INC · on record since Mar 30, 2022
Insider trading activity of Polaris Venture Partners Founders' Fund V, L.P.
- Transactions on record
- 120
- since Feb 11, 2014
- Open-market buys
- 2
- $13.1M
- Open-market sells
- 40
- $16.9M
- Companies traded
- 5
- last filing Feb 15, 2018
Figures computed from official regulatory filings — methodology.
Companies where Polaris Venture Partners Founders' Fund V, L.P. has traded
Track record of Polaris Venture Partners Founders' Fund V, L.P.
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Polaris Venture Partners Founders' Fund V, L.P.
Co-insiders of Polaris Venture Partners Founders' Fund V, L.P.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BIND Therapeutics, Inc +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 15, 2018 | Other | 18,148 | — | — | SEC |
| Feb 15, 2018 | OtherD | -6,378 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | OtherD | -1,126 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 8,140 | — | — | SEC |
| Feb 15, 2018 | OtherD | -3,995 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 7,719 | — | — | SEC |
| Feb 15, 2018 | Other | 1,404 | — | — | SEC |
| Feb 15, 2018 | OtherD | -3,205 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 5,287 | — | — | SEC |
| Feb 15, 2018 | OtherD | -498 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 255 | — | — | SEC |
| Feb 15, 2018 | Other | 191 | — | — | SEC |
| Feb 15, 2018 | Other | 280 | — | — | SEC |
| Feb 15, 2018 | OtherD | -931,174 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | OtherD | -191 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 25,571 | — | — | SEC |
| Feb 15, 2018 | OtherD | -9,311 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | OtherD | -2,050 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 498 | — | — | SEC |
| Feb 15, 2018 | OtherD | -8,140 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 205,020 | — | — | SEC |
| Feb 15, 2018 | OtherD | -1,644 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | OtherD | -771,947 | 0.00 USD | $0 | SEC |
| Feb 15, 2018 | Other | 1,126 | — | — | SEC |
| Feb 15, 2018 | OtherD | -1,404 | 0.00 USD | $0 | SEC |